Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Urinary Tract Infection
100%
Infection Prevention
100%
Evidence Review
100%
Narrative Review
100%
Regulatory Gaps
100%
Recurrent Urinary Tract Infections (rUTI)
100%
Vaginal Estrogen
100%
Postmenopausal Women
88%
Estrogen
44%
Antibiotics
33%
Clinical Practice Guidelines
22%
Antibiotic Therapy
22%
Regulatory Agencies
22%
Guideline Recommendations
22%
Evidence-based
11%
Quality of Life
11%
Patient Experience
11%
Randomized Controlled Trial
11%
Resource Utilization
11%
PubMed
11%
High Incidence
11%
Embase
11%
Microbiome
11%
Randomized Controlled Clinical
11%
Clinical Evidence
11%
Antibiotic Prophylaxis
11%
Community Safety
11%
Patient Response
11%
Participant Characteristics
11%
European Medicines Agency
11%
Epithelium
11%
Antimicrobial Stewardship
11%
Antimicrobial Use
11%
Treatment Duration
11%
Underuse
11%
Optimal Timing
11%
Health Products
11%
Safety Profile
11%
Lactobacillus
11%
Menopause
11%
Antibiotic Combination
11%
Dosing Regimen
11%
Women's Preferences
11%
Shared Decision-making
11%
Structured Narratives
11%
Target Search
11%
Trial Data
11%
Product Labeling
11%
Data Recommendation
11%
Approved Indications
11%
Incident Cost
11%
Relative Superiority
11%
Hospital Costs
11%
Estrogen Alone
11%
Primary Care Population
11%
Timing of Initiation
11%
European Association of Urology
11%
Estriol
11%
Genitourinary Syndrome of Menopause
11%
U.S. Food
11%
Preference Decision
11%
Intravaginal Estrogen
11%
UTI Prophylaxis
11%
Head-to-head Trials
11%
Trial Practice
11%
Pessary
11%
Safety Outcomes
11%
Pragmatic Study
11%
Urogenital
11%
Vaginal Health Index
11%
Therapeutic Parameters
11%
Combined Regimens
11%
Estrogen Therapy
11%
Patient-centered Research
11%
Medicine and Dentistry
Urinary Tract Infection
100%
Infection Prevention
100%
Estrogen
100%
Climacterium
30%
Postmenopause
30%
Randomized Controlled Trial
23%
Antibiotic Therapy
15%
Antimicrobial Agent
15%
Antibiotics
15%
Quality of Life
7%
Clinician
7%
Health Care Cost
7%
Base
7%
Primary Health Care
7%
Microbiome
7%
Antiinfective Agent
7%
Patient Experience
7%
Low Drug Dose
7%
Clinical Guideline
7%
Urology
7%
Antimicrobial Stewardship
7%
Epithelium
7%
Estrogen Therapy
7%
Estriol
7%
Lactobacillus
7%
Antibiotic Prophylaxis
7%
Pessary
7%
Shared Decision Making
7%
Pharmacology, Toxicology and Pharmaceutical Science
Urinary Tract Infection
100%
Estrogen
100%
Randomized Controlled Trial
21%
Antimicrobial Agent
21%
Antibiotics
14%
Antiinfective Agent
14%
Base
7%
Tablet
7%
Microbiome
7%
Antibiotic Therapy
7%
Syndrome
7%
Antibiotic Prophylaxis
7%
Estriol
7%
Intravaginal Administration
7%
Lactobacillus
7%
Pessary
7%